Marlou Janssen joins the Sonion Board of Directors

Copenhagen, January 26, 2024

Sonion is pleased to announce the appointment of Marlou Janssen to its Board of Directors.

Marlou Janssen is a senior executive with more than 25 years of experience from leadership roles at several leading global health tech companies.

Her previous roles include Vice President & General Manager of EPD Solutions at Dutch technology giant Philips, President US of Biotronik, a leading healthcare company for cardiovascular medical technology, and Vice President at medical equipment manufacturer St. Jude Medical.

Marlou Janssen currently holds several Board positions, including Member of the Board of US medical device company Field Medical, Member of the Supervisory Board of Acarix, a Swedish medical device company, Non-Executive Director of Inspiration Healthcare Group, a global provider of medical technology and Member of the Board of EBAMed, a Swiss based medical device company.

“I am excited and honoured that Marlou Janssen is joining our Board. Marlou has a great understanding of healthcare markets, a proven track-record and strong competencies within business development and strategy execution which will strengthen the Board of Sonion as we continue to build on our position as a global leader in development and manufacturing of cutting-edge components in the field of hearing health and audio. We look very much forward to working with Marlou,” said Piet Coelewij, Chair of the Board of Sonion.

Marlou Janssen said: “I am delighted to join the Board of Sonion, one of the leading manufacturers of components and solutions for hearing instruments. I hope to use my experience and expertise to contribute to further elevating the capabilities of Sonion in delivering value-based customer-focused solutions in the hearing health sector to improve people’s quality of life.”

Marlou Janssen was appointed to the Board following a general meeting on January 19th, 2024.

About Sonion

Sonion is a global leader in the development and manufacturing of micro acoustic and micro mechanical solutions for hearing instruments, high-end hearables, and in-ear earphones. Sonion is owned by Novo Holdings A/S, the holding company within the Novo Group that manages the assets of the Novo Nordisk Foundation. Read more at www.sonion.com.

Further information
Christian Nielsen
President & CEO
Mail to: cn@sonion.com
Tel: +45 20 41 98 49